Raju Vaddepally
- Oncology top 5%
- Immunology top 10%
- Pulmonary and Respiratory Medicine top 10%
- Molecular Biology
- Cancer Research
- Co-authors
- Rohan GarjeAbhinav ChandraPrakash KharelRamesh Kumar PandeyYousef ZakhariaHaythem AliMadhu P. MenonPhilip Kuriakose
- Topics
- Cancer Immunotherapy and Biomarkers (3 papers)Vascular Tumors and Angiosarcomas (1 paper)Acute Myeloid Leukemia Research (1 paper)
- Partner nations
- United StatesIndia
In The Last Decade
Raju Vaddepally
10 papers receiving 986 citations
Hit Papers
Peers
Comparison fields: 5 of 76
- Oncology 745
- Immunology 352
- Pulmonary and Respiratory Medicine 246
- Molecular Biology 202
- Cancer Research 108
Countries citing papers authored by Raju Vaddepally
This map shows the geographic impact of Raju Vaddepally's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raju Vaddepally with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raju Vaddepally more than expected).
Fields of papers citing papers by Raju Vaddepally
This network shows the impact of papers produced by Raju Vaddepally. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raju Vaddepally. The network helps show where Raju Vaddepally may publish in the future.
Co-authorship network of co-authors of Raju Vaddepally
This figure shows the co-authorship network connecting the top 25 collaborators of Raju Vaddepally. A scholar is included among the top collaborators of Raju Vaddepally based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raju Vaddepally. Raju Vaddepally is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 34 | |
| 2 | 3 | |
| 3 | 2 | |
| 4 | 39 | |
| 5 | 13 | |
| 6 | Review of Indications of FDA-Approved Immune Checkpoint Inhibitors per NCCN Guidelines with the Level of Evidencebreakdown → | 895 |
| 7 | 2 | |
| 8 | 2 | |
| 9 | 6 | |
| 10 | 1 |
About Raju Vaddepally
Raju Vaddepally is a scholar working on Oncology, Hematology and Emergency Medicine, having authored 10 papers that have together received 997 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Vascular Tumors and Angiosarcomas (1 paper) and Acute Myeloid Leukemia Research (1 paper). The work is most often cited by research in Oncology (745 citations), Immunology (352 citations) and Pulmonary and Respiratory Medicine (246 citations). Raju Vaddepally has collaborated with scholars based in United States and India. Frequent co-authors include Rohan Garje, Abhinav Chandra, Prakash Kharel, Ramesh Kumar Pandey, Yousef Zakharia, Haythem Ali, Madhu P. Menon, Philip Kuriakose, Victor Priego and Francis M. Senecal. Their work appears in journals such as Journal of Clinical Oncology, Cancers and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.